Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Lymphoid 2

Conditions

Neoplasms, Plasma Cell 2Neoplasms 2Lymphoma 2Leukemia 2Infections 2Lymphoma, Non-Hodgkin 1

Interventions

Dexamethasone 5Trimethoprim, Sulfamethoxazole Drug Combination 4gamma-Globulins 3Lenalidomide 3Ciprofloxacin 3Bortezomib 3pomalidomide 2fludarabine phosphate 2fludarabine 2elotuzumab 2carfilzomib 2Radiotherapy 2Immunoglobulins, Intravenous 2Cyclophosphamide 2Amoxicillin-Potassium Clavulanate Combination 2siltuximab 1selinexor 1nirogacestat 1iberdomide 1daratumumab 1belantamab mafodotin 1Positron-Emission Tomography 1Melphalan 1Interviews as Topic 1Immunoglobulins 1Focus Groups 1Fecal Microbiota Transplantation 1Clonal Hematopoiesis 1Clavulanic Acid 1Chromatin Immunoprecipitation Sequencing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Plasma Cell × Immunoglobulins, Intravenous × Clear all
NCT07202052 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms, Neoplasms, Plasma Cell

NCT07202065 2025-10-07

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

Monash University

Phase 2/3 Recruiting
900 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Infections, Leukemia, Lymphoma, Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡